This book presents an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer. It is structured in a way so readers may begin with chapters that most interest them and work through the rest of the chapters in the order of their choice.Proc Am Soc Clin Oncol 2004; 14S(4647). ... Low dose docetaxel, estramustine and thalidomide followed by maintenance thalidomide for the treatment of hormone refractory ... MDX-010 Chapter 12 / Targeted Therapies for Prostate Cancer 289.
|Title||:||Molecular Targeting in Oncology|
|Author||:||Howard L. Kaufman, Scott Wadler, Karen Antman|
|Publisher||:||Springer Science & Business Media - 2007-12-26|